Mancini Marianna
Chief Operating Officer
Mancini Marianna has filed 3 SEC Form 4 filings (10 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jul 30, 2026.
On the most recent filing, Mancini Marianna is listed as Chief Operating Officer at Viking Therapeutics, Inc. Inside the rolling window, Mancini Marianna reported no open-market purchases and 3 open-market sales totaling $2.7M in VKTX. The largest disclosed transaction in the window is a sale of 57,661 VKTX shares on Jan 5, 2026, worth $1.9M.
Companies traded
Other insiders at VKTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.7M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Mancini Marianna made?
Mancini Marianna has filed 3 SEC Form 4 filings (10 transaction rows) across 1 company since 2025.
Which companies does Mancini Marianna trade?
Mancini Marianna has filed SEC Form 4 disclosures for 1 company, including VKTX.
When was Mancini Marianna's most recent SEC Form 4 filing?
Mancini Marianna's most recent SEC Form 4 filing on Tracefour is dated Jul 30, 2026.
What is Mancini Marianna's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Mancini Marianna is listed as Chief Operating Officer.
What is Mancini Marianna's total buy and sell value in the current window?
Inside the rolling retention window, Mancini Marianna bought $0 and sold $2.7M based on SEC Form 4 filings.
What was Mancini Marianna's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 57,661 VKTX shares on 2026-01-05, worth $1.9M, per SEC Form 4 filings.